Related Experiment Videos
Recurrent cutaneous leishmaniasis: a role for persistent parasites?
1Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
Parasitology Today (Personal Ed.)
|January 1, 1994
Summary
Persistent Leishmania infections are common and can cause recurrent leishmaniasis, especially in immunocompromised individuals. Understanding parasite persistence is key for developing new treatments and vaccines.
Area of Science:
- Parasitology
- Immunology
- Infectious Diseases
Background:
- Leishmaniasis is increasingly recognized as an opportunistic infection in immunosuppressed populations.
- Recurrent disease may result from the reactivation of persistent Leishmania parasites.
- Cutaneous leishmaniasis in humans and a mouse model are key areas of study.
Purpose of the Study:
- To review evidence implicating persistent Leishmania infections in recurrent leishmaniasis.
- To highlight the utility of a mouse model for studying parasite persistence.
- To discuss the implications of parasite persistence for patient risk identification and therapeutic development.
Main Methods:
- Review of existing scientific literature on Leishmania infections.
- Emphasis on studies involving human cutaneous leishmaniasis and a mouse model.
- Analysis of data related to parasite persistence and disease recurrence.
Main Results:
- Parasite persistence appears to be a common characteristic of Leishmania infections.
- A robust laboratory model facilitates detailed investigation of Leishmania persistence.
- Findings underscore the link between persistent infection and recurrent disease.
Conclusions:
- Parasite persistence is a significant factor in the pathogenesis of recurrent leishmaniasis.
- Understanding persistence can aid in identifying at-risk individuals and developing novel therapies.
- Implications for future anti-Leishmania vaccine design are suggested.